Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

SoftBank Opportunity Fund has backed a debt and equity round that reportedly valued the hair appointment management platform at $250m.

Google and existing investor Novo contributed to a series G2 round valuing the precision medicine developer at $8.1bn post-money.

Sidewalk Labs' health provision spinoff took its valuation above $1bn and its overall funding to about $300m in a General Catalyst-led series C round.

The series D round helped Sedgwick and NewYork-Presbyterian-backed care optimisation platform developer LeanTaas push its overall funding past the $250m mark.

The mitochondrial disease therapy developer's latest round was co-led by Novo Ventures and backed by returning investor Lundbeckfonden Ventures.

Rex Healthcare’s venture capital unit will exit the cancer diagnostics system developer, which has agreed to an acquisition by Olympus.

Koch Industries took part in a series B round for the identity management platform developer that increased its total funding to $105m since its launch earlier this year.

S&P Global helped the crypto data software provider hike its overall funding to nearly $40m in a series C round led by State Street Corporation.